FR10C0012I2 - - Google Patents

Info

Publication number: FR10C0012I2
Authority: FR; France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Active

Application number

FR10C0012C

Other languages

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Pierre Fabre Medicament SA

Original Assignee

Pierre Fabre Medicament SA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-07-21

Filing date

2010-03-04

Publication date

2011-04-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9449457&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FR10C0012(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-03-04 Application filed by Pierre Fabre Medicament SA filed Critical Pierre Fabre Medicament SA

2010-04-16 Publication of FR10C0012I1 publication Critical patent/FR10C0012I1/fr

2011-04-01 Application granted granted Critical

2011-04-01 Publication of FR10C0012I2 publication Critical patent/FR10C0012I2/fr

Status Active legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
- C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Compounds Of Unknown Constitution (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Saccharide Compounds (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

FR10C0012C 1993-07-21 2010-03-04 Active FR10C0012I2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9308948A FR2707988B1 (en)	1993-07-21	1993-07-21	New antimitotic derivatives of binary alkaloids of catharantus rosesus, process for their preparation and pharmaceutical compositions comprising them.
PCT/FR1994/000898 WO1995003312A1 (en)	1993-07-21	1994-07-19	Novel antimitotic binary alkaloid derivatives extracted from catharanthus roseus

Publications (2)

Publication Number	Publication Date
FR10C0012I1 FR10C0012I1 (en)	2010-04-16
FR10C0012I2 true FR10C0012I2 (en)	2011-04-01

Family

ID=9449457

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
FR9308948A Expired - Lifetime FR2707988B1 (en)	1993-07-21	1993-07-21	New antimitotic derivatives of binary alkaloids of catharantus rosesus, process for their preparation and pharmaceutical compositions comprising them.
FR10C0012C Active FR10C0012I2 (en)	1993-07-21	2010-03-04

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
FR9308948A Expired - Lifetime FR2707988B1 (en)	1993-07-21	1993-07-21	New antimitotic derivatives of binary alkaloids of catharantus rosesus, process for their preparation and pharmaceutical compositions comprising them.

Country Status (15)

Country	Link
US (1)	US5620985A (en)
EP (1)	EP0710240B1 (en)
JP (1)	JP3606872B2 (en)
AT (1)	ATE146477T1 (en)
AU (1)	AU693460B2 (en)
BR (1)	BR1100311A (en)
CA (1)	CA2167694C (en)
DE (2)	DE69401216T2 (en)
DK (1)	DK0710240T3 (en)
ES (1)	ES2097659T3 (en)
FR (2)	FR2707988B1 (en)
GR (1)	GR3022659T3 (en)
LU (1)	LU91660I2 (en)
NZ (2)	NZ269172A (en)
WO (1)	WO1995003312A1 (en)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2737208A1 (en) *	1995-07-28	1997-01-31	Pf Medicament	Fluorinated vindoline derivs - and their reaction products with catharanthine having anti-cancer properties
FR2761990B1 (en) *	1997-04-10	1999-06-25	Pf Medicament	ANTIMITOTIC HALOGEN DERIVATIVES OF VINCA ALKALOIDS
FR2783522A1 (en) *	1998-09-21	2000-03-24	Pf Medicament	New Vinca alkaloid derivatives useful as antitumor agents for treating cancer
GB0011903D0 (en) *	2000-05-18	2000-07-05	Astrazeneca Ab	Combination chemotherapy
US6890558B2 (en) *	2002-05-31	2005-05-10	R.P. Scherer Technologies, Inc.	Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
WO2005055939A2 (en)	2003-12-04	2005-06-23	Amr Technology, Inc.	Vinca derivatives
US7235564B2 (en)	2003-12-04	2007-06-26	Amr Technology, Inc.	Vinorelbine derivatives
FR2863891B1 (en) *	2003-12-23	2006-03-24	Pf Medicament	PHARMACEUTICAL COMPOSITION OF VINFLUNIN FOR PARENTAL ADMINISTRATION, PROCESS FOR PREPARATION AND USE
US20110015221A1 (en) *	2003-12-23	2011-01-20	Pierre Fabre Medicament	Pharmaceutical composition of vinflunine which is intended for parenteral administration preparation method thereof and use of same
EP1732947B1 (en) *	2004-03-05	2011-04-27	Vegenics Pty Ltd	Growth factor binding constructs materials and methods
FR2894966B1 (en) *	2005-12-20	2008-03-14	Pierre Fabre Medicament Sa	NEW CRYSTALLINE FORM OF VINFLUNINE
EP1989212B1 (en)	2006-02-17	2013-06-19	Cascade Prodrug Inc.	Treatment of hyperproliferative diseases with vinca alkaloid n-oxide and analogs
CN101108859A (en) *	2006-07-17	2008-01-23	上海恒瑞医药有限公司	Vinblastine compound, method of preparing the same and use in medicament thereof
WO2008033935A2 (en) *	2006-09-12	2008-03-20	Amr Technology, Inc.	Vinorelbine derivatives
WO2008033930A2 (en) *	2006-09-12	2008-03-20	Amr Technology, Inc.	Vinca derivatives
FR2905949B1 (en)	2006-09-20	2008-11-21	Pierre Fabre Medicament Sa	FLUORINE DERIVATIVES OF CATHARANTHIN, PREPARATION THEREOF AND THEIR USE AS PRECURSORS OF ALKALOIDS DIMERES DE VINCA
CN101235046B (en) *	2007-01-29	2010-09-08	中国科学院上海药物研究所	Vinblastine derivative, its preparation method and use, and pharmaceutical composition containing the derivative
FR2912406B1 (en) *	2007-02-13	2009-05-08	Pierre Fabre Medicament Sa	VINFLUNIN ANHYDROUS CRYSTAL SALTS, PROCESS FOR THEIR PREPARATION AND USE AS MEDICAMENT AND MEANS FOR PURIFYING VINFLUNIN.
EP1997534A1 (en) *	2007-05-31	2008-12-03	Pierre Fabre Medicament	Cancer treatment combination therapy comprising vinflunine and trastuzumab
FR2918567B1 (en) *	2007-07-11	2012-08-03	Pf Medicament	STABLE PHARMACEUTICAL COMPOSITION OF A WATER SOLUBLE SALT OF VINORELBINE.
FR2918566B1 (en) *	2007-07-11	2009-10-09	Pierre Fabre Medicament Sa	STABLE PHARMACEUTICAL COMPOSITION OF A WATER SOLUBLE SALT OF VINFLUNINE.
US20090076055A1 (en) *	2007-09-14	2009-03-19	Protia, Llc	Deuterium-enriched vinflunine
US8173621B2 (en)	2008-06-11	2012-05-08	Gilead Pharmasset Llc	Nucleoside cyclicphosphates
US8716263B2 (en)	2008-12-23	2014-05-06	Gilead Pharmasset Llc	Synthesis of purine nucleosides
US8551973B2 (en)	2008-12-23	2013-10-08	Gilead Pharmasset Llc	Nucleoside analogs
PA8855601A1 (en)	2008-12-23	2010-07-27		NUCLEOSID FORFORMIDATES
ES2575160T3 (en)	2010-03-15	2016-06-24	The Board Of Trustees Of The University Of Illinois	Inhibitors of the interactions that bind the alpha subunit of beta integrin-protein G
WO2011123668A2 (en)	2010-03-31	2011-10-06	Pharmasset, Inc.	Stereoselective synthesis of phosphorus containing actives
WO2012087943A2 (en)	2010-12-20	2012-06-28	The Regents Of The University Of Michigan	Inhibitors of the epidermal growth factor receptor-heat shock protein 90 binding interaction
CN103788117A (en) *	2012-10-30	2014-05-14	何小解	Technology for continuously synthesizing Dehydrate Catharanthine, vinorelbine and Vinflunine
HU230462B1 (en)	2013-05-30	2016-07-28	Richter Gedeon Nyrt.	A new bis-indole alkaloids as anticancer drugs
AU2015205995A1 (en)	2014-01-15	2016-07-28	Centre National De La Recherche Scientifique (Cnrs)	Water soluble 4-azapodophyllotoxin analogs
EP3250611B1 (en)	2015-01-26	2021-04-21	The University of Chicago	Car t-cells recognizing cancer-specific il 13r-alpha2
CN107683289B (en)	2015-01-26	2021-08-06	芝加哥大学	IL13Rα2 binding agents and their use in cancer therapy
CN108779129A (en) *	2016-03-09	2018-11-09	赛比亚斯药业股份公司	Vinorelbine list tartrate and its medicinal usage
EP3481422A1 (en)	2016-07-06	2019-05-15	Pierre Fabre Medicament	Vinflunine and pd1 and/or pdl1 inhibitor as pharmaceutical combination
MA49849A (en)	2017-08-07	2020-06-17	Amgen Inc	TREATMENT OF NEGATIVE TRIPLE BREAST CANCER OR COLORECTAL CANCER CONTAINING HEPATIC METASTASIS WITH ANTI-PD-L1 ANTIBODY AND ONCOLYTIC VIRUS
EP3941944A4 (en)	2019-03-20	2022-11-30	The Regents of the University of California	BISPECIFIC CLAUDIN-6 ANTIBODIES
BR112021018608A2 (en)	2019-03-20	2021-11-23	Univ California	Antibodies to claudin-6 and drug conjugates
WO2020222668A1 (en)	2019-04-30	2020-11-05	Instituto de Medicina Molecular João Lobo Antunes	Rank pathway inhibitors in combination with cdk inhibitors
JP7763666B2 (en)	2019-06-24	2025-11-04	アムジェンインコーポレイテッド	Inhibition of SIRPγ for cancer treatment
FR3140369B1 (en)	2022-10-04	2025-07-25	Univ Poitiers	Process for the fluorination and/or cyclization of an alkene or amino alkyne in continuous flow and installation for implementing the process

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2296418B1 (en) *	1974-12-30	1978-07-21	Anvar
US4110330A (en) *	1977-05-27	1978-08-29	Eli Lilly And Company	5'-Acetonylvincristine and related compounds
US4203898A (en) *	1977-08-29	1980-05-20	Eli Lilly And Company	Amide derivatives of VLB, leurosidine, leurocristine and related dimeric alkaloids
US4307100A (en) *	1978-08-24	1981-12-22	Agence Nationale De Valorisation De La Recherche (Anvar)	Nor bis-indole compounds usable as medicaments
US4320058A (en) *	1980-12-29	1982-03-16	Eli Lilly And Company	20'-Hydroxyvinblastine and related compounds
HU193772B (en) *	1985-06-12	1987-11-30	Richter Gedeon Vegyeszet	Process for producing new nitro-bis-indole derivatives

1993
- 1993-07-21 FR FR9308948A patent/FR2707988B1/en not_active Expired - Lifetime
1994
- 1994-07-19 NZ NZ269172A patent/NZ269172A/en not_active IP Right Cessation
- 1994-07-19 AT AT94922935T patent/ATE146477T1/en active
- 1994-07-19 CA CA002167694A patent/CA2167694C/en not_active Expired - Lifetime
- 1994-07-19 ES ES94922935T patent/ES2097659T3/en not_active Expired - Lifetime
- 1994-07-19 WO PCT/FR1994/000898 patent/WO1995003312A1/en not_active Ceased
- 1994-07-19 EP EP94922935A patent/EP0710240B1/en not_active Expired - Lifetime
- 1994-07-19 DE DE69401216T patent/DE69401216T2/en not_active Expired - Lifetime
- 1994-07-19 JP JP50497395A patent/JP3606872B2/en not_active Expired - Lifetime
- 1994-07-19 DK DK94922935.5T patent/DK0710240T3/en active
- 1994-07-19 DE DE122010000012C patent/DE122010000012I1/en active Pending
- 1994-07-19 AU AU72666/94A patent/AU693460B2/en not_active Expired
- 1994-07-19 US US08/578,669 patent/US5620985A/en not_active Expired - Lifetime
1997
- 1997-02-26 GR GR970400346T patent/GR3022659T3/en unknown
- 1997-04-22 BR BR1100311-1A patent/BR1100311A/en active IP Right Grant
- 1997-08-27 NZ NZ328612A patent/NZ328612A/en not_active IP Right Cessation
2010
- 2010-03-04 FR FR10C0012C patent/FR10C0012I2/fr active Active
- 2010-03-10 LU LU91660C patent/LU91660I2/en unknown

Also Published As

Publication number	Publication date
JPH09500634A (en)	1997-01-21
LU91660I2 (en)	2010-05-10
NZ328612A (en)	2000-05-26
EP0710240A1 (en)	1996-05-08
US5620985A (en)	1997-04-15
AU7266694A (en)	1995-02-20
WO1995003312A1 (en)	1995-02-02
ES2097659T3 (en)	1997-04-01
DE122010000012I1 (en)	2010-07-08
DK0710240T3 (en)	1997-06-02
NZ269172A (en)	1997-10-24
FR2707988A1 (en)	1995-01-27
GR3022659T3 (en)	1997-05-31
JP3606872B2 (en)	2005-01-05
AU693460B2 (en)	1998-07-02
FR2707988B1 (en)	1995-10-13
ATE146477T1 (en)	1997-01-15
DE69401216T2 (en)	1997-07-03
BR1100311A (en)	1999-08-31
FR10C0012I1 (en)	2010-04-16
DE69401216D1 (en)	1997-01-30
CA2167694C (en)	2007-03-06
CA2167694A1 (en)	1995-02-02
EP0710240B1 (en)	1996-12-18

Publication	Publication Date	Title
FR10C0012I2 (en)	2011-04-01
DK0638912T3 (en)	1997-05-12
EP0663652A3 (en)	1995-08-30
IN178499B (en)	1997-05-03
TW241415B (en)	1995-02-21
DK114893D0 (en)	1993-10-14
FR2707030B1 (en)	1995-07-28
DK18793A (en)	1994-08-19
IN183201B (en)	1999-10-02
TW287189B (en)	1996-10-01
DK53594A (en)	1994-12-08
FR2706732B1 (en)	1995-08-11
DK76793D0 (en)	1993-06-28
EP0661739A3 (en)	1995-08-16
TW236682B (en)	1994-12-21
FR2710424B1 (en)	1997-02-21
IN182093B (en)	1998-12-26
ECSDI930113S (en)	1994-07-19
DK9700281U1 (en)	1997-07-15
ECSDI930096S (en)	1994-01-12
DK67893D0 (en)	1993-06-09
DK47093A (en)	1994-10-27
ECSDI930145S (en)	1994-04-20
ECSDI930106S (en)	1994-02-17
ECSDI930098S (en)	1994-02-09